Public concern has only grown, says ICB, while evidence of benefits remains thin
One of the UK's biggest health regions has doubled down on its decision not to join the NHS Federated Data Platform (FDP), owing to concerns over its lead supplier, Palantir, and a lack of evidence for the technology's benefits.
Greater Manchester Integrated Care Board (ICB), which manages health services for 2.8 million people, deferred a decision on whether to sign up to the FDP last year. It is the only ICB in England to do so.
A board meeting in May 2025 heard that NHS England had not addressed the ICB's concerns around risks. The ICB added that Greater Manchester's capability in data analytics was greater than what the FDP currently offered.
REG AD
In a November meeting, Greater Manchester ICB said it would review its position. However, a recent Freedom of Information response said that review was now off the table, and the ICB would stick with its decision not to join the FDP.
REG AD
"It was proposed that a paper would be produced in due course to guide a review of the ICB position," the response said. "This paper has not been produced yet and work has not started on this paper because it's clear that the public concerns have heightened rather than diminished since the deferral decision has been taken and there does not appear to be any compelling evidence that the value proposition for NHS GM from FDP has materially changed in favour of adoption."
NHS England has been offered the opportunity to comment.
The FDP was created by Palantir under a much-criticized £330 million procurement for a seven-year contract awarded in November 2023. NHS England signed the deal after it awarded £60 million to the vendor without competition during the pandemic. The FDP is designed to improve information flow through various NHS organizations and reduce the backlog in non-urgent "elective care," which skyrocketed during the COVID-19 outbreak.
NHS England confirmed that Palantir staff could access patient data following a change in policy, provoking outrage from those concerned about the US spy-tech firm's position at the heart of NHS data after a series of outspoken political positions from its leadership.
Last month, the junior minister responsible for the FDP said the government would consider using a break clause in the FDP contract to remove Palantir, although he defended the system's performance. Liberal Democrat MP Martin Wrigley claimed the NHS was locked into the Palantir contract and owned none of the software or intellectual property resulting from it. ®